Literature DB >> 16188494

Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues.

Seiko Masuda1, Makoto Murakami, Yukio Ishikawa, Toshiharu Ishii, Ichiro Kudo.   

Abstract

The secretory phospholipase A2 (sPLA2) family in mammals contains more than 10 enzymes. In this study, we examined by immunohistochemistry the localization of six sPLA2s (IIA, IID, IIE, IIF, V and X) in human heart, kidney, liver and stomach. In normal hearts, sPLA2-IIA was detected in coronary vascular smooth muscle cells (VSMC) and sPLA2-V in cardiomyocytes beneath the endocardium. In infarcted hearts, expression of these two enzymes was markedly increased in damaged cardiomyocytes, and expression of sPLA2-IID and-IIE, which was undetectable in normal hearts, was elevated in damaged cardiomyocytes and VSMC, respectively. In infarcted kidneys, sPLA2-IIA and-V were markedly induced in the uriniferous tubular epithelium. In livers affected by viral hepatitis, sPLA2-IIA and-V were expressed in hepatocytes with fatty degeneration. In the gastric glands exhibiting intestinal metaplasia, sPLA2-IIA was localized in the glandular base, sPLA2-IID and-V in the glandular body epithelium, sPLA2-IIE and-IIF in goblet cells in the foveolar epithelium, and sPLA2-X in both glandular body epithelial cells and foveolar epithelial goblet cells. In the gastric submucosal tissues, sPLA2-IIA and-IIE were located in VSMC and sPLA2-V was in the interstitial fibroblasts. In addition, sPLA2-IIA,-IIE,-IIF and-X were highly expressed in gastric signet ring cell carcinoma. Thus, individual sPLA2s exhibit unique cellular localizations in each tissue, suggesting their distinct roles in pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16188494     DOI: 10.1016/j.bbalip.2005.08.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  25 in total

1.  Production of vascular endothelial growth factors from human lung macrophages induced by group IIA and group X secreted phospholipases A2.

Authors:  Francescopaolo Granata; Annunziata Frattini; Stefania Loffredo; Rosaria I Staiano; Angelica Petraroli; Domenico Ribatti; Rob Oslund; Michael H Gelb; Gerard Lambeau; Gianni Marone; Massimo Triggiani
Journal:  J Immunol       Date:  2010-03-31       Impact factor: 5.422

2.  Group V secretory phospholipase A2 amplifies the induction of cyclooxygenase 2 and delayed prostaglandin D2 generation in mouse bone marrow culture-derived mast cells in a strain-dependent manner.

Authors:  Bruno L Diaz; Yoshiyuki Satake; Eriya Kikawada; Barbara Balestrieri; Jonathan P Arm
Journal:  Biochim Biophys Acta       Date:  2006-09-22

3.  Regulation of sPLA2-IID in Human Decidua: Insights Into the Complexity of the Prostaglandin Pathway in Labor.

Authors:  Andrea A Mosher; Kelly J Rainey; Brigitta Riley; Hayley S Levinson; Angela E Vinturache; Stephen L Wood; Donna M Slater
Journal:  Reprod Sci       Date:  2014-01-18       Impact factor: 3.060

Review 4.  Molecular tissue changes in early myocardial ischemia: from pathophysiology to the identification of new diagnostic markers.

Authors:  Aleksandra Aljakna; Tony Fracasso; Sara Sabatasso
Journal:  Int J Legal Med       Date:  2018-01-23       Impact factor: 2.686

5.  Group V secreted phospholipase A2 plays a protective role against aortic dissection.

Authors:  Kazuhiro Watanabe; Yoshitaka Taketomi; Yoshimi Miki; Kiyotaka Kugiyama; Makoto Murakami
Journal:  J Biol Chem       Date:  2020-06-01       Impact factor: 5.157

6.  Epigenetic control of group V phospholipase A2 expression in human malignant cells.

Authors:  Mario Menschikowski; Albert Hagelgans; Brit Nacke; Carsten Jandeck; Olga A Mareninova; Liana Asatryan; Gabriele Siegert
Journal:  Tumour Biol       Date:  2015-12-29

7.  Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction.

Authors:  David H Adler; Joy D Cogan; John A Phillips; Nathalie Schnetz-Boutaud; Ginger L Milne; Tina Iverson; Jeffrey A Stein; David A Brenner; Jason D Morrow; Olivier Boutaud; John A Oates
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

8.  The enteropathy of prostaglandin deficiency.

Authors:  David H Adler; John A Phillips; Joy D Cogan; Tina M Iverson; Nathalie Schnetz-Boutaud; Jeffrey A Stein; David A Brenner; Ginger L Milne; Jason D Morrow; Oliver Boutaud; John A Oates
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

9.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

10.  Secretory group V phospholipase A2 regulates acute lung injury and neutrophilic inflammation caused by LPS in mice.

Authors:  Nilda M Muñoz; Angelo Y Meliton; Lucille N Meliton; Steven M Dudek; Alan R Leff
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-03-13       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.